| Authors: |
Schram AM; Memorial Sloan Kettering Cancer Center, New York, New York., Naqash AR; OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Sarah Cannon Research Institute, Nashville, Tennessee., Haura EB; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Riess JW; UC Davis Comprehensive Cancer Center, Sacramento, California., Ulahannan SV; OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.; Sarah Cannon Research Institute, Nashville, Tennessee., Ou SI; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California., Munster PN; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Cheng ML; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California., Gustafson WC; Revolution Medicines, Redwood City, California., Bitman B; Revolution Medicines, Redwood City, California., Friedman R; Revolution Medicines, Redwood City, California., Penn R; Revolution Medicines, Redwood City, California., Kar S; Revolution Medicines, Redwood City, California., Seshadri V; Revolution Medicines, Redwood City, California., Wang Z; Revolution Medicines, Redwood City, California., Tao L; Revolution Medicines, Redwood City, California., Yang YC; Revolution Medicines, Redwood City, California., Singh M; Revolution Medicines, Redwood City, California., Burris HA; Sarah Cannon Research Institute, Nashville, Tennessee., Meyerowitz JG; Revolution Medicines, Redwood City, California. |
